ANUGESIC HC

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

PRAMOCAINE HYDROCHLORIDE HYDROCORTISONE ACETATE BENZYL BENZOATE BISMUTH OXIDE BALSAM PERU ZINC OXIDE BISMUTH SUBGALLATE

Available from:

Pfizer Healthcare Ireland

Pharmaceutical form:

Suppositories

Authorization date:

2000-03-15

Summary of Product characteristics

                                License
Summary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT
Anugesic HC Suppositories
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suppository
The product is a buff coloured suppository.
4 CLINICAL PARTICULARS
4.1 Therapeutic Indications
Anugesic HC Suppositories are indicated for the comprehensive symptomatic treatment of severe and acute
discomfort or pain associated with internal and external haemorrhoids, proctitis, cryptitis, anal fissures,
pruritus ani and perianal sinuses. Also indicated post-operatively in ano-rectal surgical procedures.
4.2 Posology and method of administration
Intrarectal.
Adults: Remove plastic cover and insert one suppository into the anus at night, in the morning and after
each evacuation.
Not to be taken orally.
Elderly (over 65 years): As for adults.
Children: Not recommended.
4.3 Contraindications
Tubercular, fungal and viral lesions including herpes simplex, vaccinia and varicella.
History of sensitivity to any of the constituents.
Each 2.8 g suppository contains:
Pramocaine Hydrochloride
27
mg
Hydrocortisone Acetate
5
mg
Benzyl Benzoate
33
mg
Bismuth oxide
24
mg
Balsam Peru
49
mg
Zinc Oxide
296
mg
Bismuth Subgallate
59
mg
Irish Medicines Board
__________________________________________________________________________________________________
                                
                                Read the complete document
                                
                            

View documents history